GE mosquito company Oxitec has admitted a major risk of its technology – reducing one mosquito species may increase the numbers of a second disease-carrying species. […]
|
||||||
|
More than 270,000 people have raised concerns over the US FDA’s review of Oxitec’s planned release of genetically engineered mosquitoes in Florida. […] This article, written by an entomologist and mosquito vector control expert, argues why genetic modification of mosquitoes is no answer to mosquito-borne diseases. […] This report explains why the proposed field release of GM diamondback moths in New York is fraught with flaws, risks, missing safeguards and insufficient regulation. […] GeneWatch UK briefing summarizing the concerns related to GM mosquitoes. […] This report warns that GM insect factories could spread antibiotic resistant bacteria into the environment, posing a risk to human health. […] Recent research from Panama raises questions on the strategy of releasing GM Aedes aegypti mosquitoes in a bid to control dengue, given the close similarities it has with another mosquito species, Aedes albopictus. […] The U.S. is considering an application for the field release of GE Diamondback moths in New York State. However, analyses by GeneWatch UK find several serious gaps in the assessment. […] Civil society groups have expressed alarm at an increase in dengue incidence, leading to an emergency decree, in a town in Brazil where releases of GM mosquitoes are taking place. […] Environmental and civil society groups warn the Brazilian regulator of GMOs, CTNBio, not to approve commercial releases of GM mosquitoes in Brazil without full public consultation, access to conclusive field trials data and a post release monitoring plan. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||